Antibody 10-1074 suppresses viremia in HIV-1-infected individuals-Reference-Cited by-同舟云学术

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Published:2017-01-16 Issue:2 Volume:23 Page:185-191
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Caskey Marina,Schoofs Till,Gruell Henning,Settler Allison,Karagounis Theodora,Kreider Edward F^ORCID,Murrell Ben,Pfeifer Nico^ORCID,Nogueira Lilian,Oliveira Thiago Y,Learn Gerald H,Cohen Yehuda Z,Lehmann Clara,Gillor Daniel,Shimeliovich Irina,Unson-O'Brien Cecilia,Weiland Daniela,Robles Alexander,Kümmerle Tim,Wyen Christoph,Levin Rebeka,Witmer-Pack Maggi,Eren Kemal,Ignacio Caroline,Kiss Szilard,West Anthony P,Mouquet Hugo,Zingman Barry S,Gulick Roy M,Keler Tibor,Bjorkman Pamela J,Seaman Michael S,Hahn Beatrice H,Fätkenheuer Gerd,Schlesinger Sarah J,Nussenzweig Michel C,Klein Florian

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4268.pdf

Reference66 articles.

1. Klein, F. et al. Antibodies in HIV-1 vaccine development and therapy. Science 341, 1199–1204 (2013).

2. Hraber, P. et al. Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection. AIDS 28, 163–169 (2014).

3. West, A.P. Jr. et al. Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell 156, 633–648 (2014).

4. Mikell, I. et al. Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog. 7, e1001251 (2011).

5. Burton, D.R. & Mascola, J.R. Antibody responses to envelope glycoproteins in HIV-1 infection. Nat. Immunol. 16, 571–576 (2015).

Cited by 422 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging trends and therapeutic applications of monoclonal antibodies;Gene;2024-10

2. Impact of glycosylation on viral vaccines;Carbohydrate Polymers;2024-10

3. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

4. The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity;Journal of Virology;2024-09-09

5. Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection;Nature Communications;2024-08-29